UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: May 17, 2004
LEE PHARMACEUTICALS
(Exact name of registrant as specified in its charter)
California |
| 1-7335 |
| 95-2680312 |
(State or other jurisdiction of |
| (Commission File No.) |
| (I.R.S. Employer |
| ||||
1444 Santa Anita Avenue, South El Monte, California 91733 | ||||
(Address of principal executive offices) | ||||
| ||||
(626) 442-3141 | ||||
(Registrant’s telephone number, including area code) |
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On May 17, 2004, Lee Pharmaceuticals publicly announced by means of a press release its second quarter ended March 31, 2004 financial results. The full text of Lee Pharmaceuticals’ press release is attached as Exhibit 99.1 and is incorporated by reference in this Item 12 of Form 8-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| LEE PHARMACEUTICALS | ||||
|
| ||||
|
| ||||
Date: | May 17, 2004 |
| By: | Ronald G. Lee |
|
|
| RONALD G. LEE | |||
|
| PRESIDENT | |||
2